Please use this identifier to cite or link to this item:
|Title:||Verapamil as prophylactic treatment for atrial fibrillation after lung operations||Authors:||VAN MIEGHEM, Walter
|Issue Date:||1996||Source:||Annals of thoracic surgery, 61. p. 1083-1085||Abstract:||Background. Atrial fibrillation is a frequently occurring arrhythmia after thoracic operations. Preventive strategies for this complication have been extensively evaluated after cardiac operations. Methods. We performed a prospective, open randomized study, comparing intravenous verapamil and placebo in 199 patients after pneumonectomy or lobectomy at the University Hospital of Leuven. Verapamil was administered as a bolus of 10 mg over 2 minutes followed by a 30-minute infusion of 0.375 mg/min and then 0.125 mg/min for 3 days. The patients were continuously monitored in the postoperative intensive care unit. Results. Atrial fibrillation occurred in 15% of the patients receiving placebo and in 8% of the patients receiving verapamil (difference not significant). The verapamil infusion was interrupted in 9% of the patients because of bradycardia and in 14% because of hypotension. Conclusions. If tolerated, continuous intravenous verapamil infusion showed only a modest prophylactic efficacy for the occurrence of atrial fibrillation after lung operations. In the dose employed the verapamil infusion was accompanied with a high incidence of side effects necessitating interruption of the therapy.||Document URI:||http://hdl.handle.net/1942/5611||Link to publication:||http://ats.ctsnetjournals.org/cgi/content/abstract/61/4/1083?maxtoshow=&HITS=10&hits=10&RESULTFORMAT=1&title=Verapamil+as+prophylactic+treatment+&andorexacttitle=and&andorexacttitleabs=and&andorexactfulltext=and&searchid=1&FIRSTINDEX=0&sortspec=relevance&resourcetype=HWCIT||Type:||Journal Contribution|
|Appears in Collections:||Non-affiliated authors|
Show full item record
checked on May 24, 2022
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.